Department of Hematology
血液内科 · Dongguan People's Hospital, Dongguan
Established as an independent department in 2005, this unit treats blood disorders including leukemia, lymphoma, anemia, and bleeding conditions. Diagnostic methods include morphological, immunological, cytogenetic, and molecular testing. Treatments offered include high-dose chemotherapy, autologous hematopoietic stem cell transplantation, leukapheresis, and molecular targeted therapies such as all-trans retinoic acid, arsenic trioxide, imatinib, and rituximab. The department also manages aplastic anemia with immunosuppressive therapy, refractory thrombocytopenic purpura with intravenous immunoglobulin or splenectomy, and thrombotic thrombocytopenic purpura with plasma exchange. It addresses blood diseases related to occupational poisoning and performs bone marrow biopsies for complex diagnoses.
Conditions and treatments
- Treatment of acute and chronic leukemia
- Autologous hematopoietic stem cell transplantation
- Molecular targeted therapy for lymphoma and leukemia
- Management of aplastic anemia and myelodysplastic syndromes
- Treatment of thrombocytopenic purpura and hemophilia
- Diagnosis and treatment of occupational poisoning-related blood diseases
Key facts
- The department was formally established in January 2005.
- The unit has 58 beds and averages over 50 inpatients per day.
- Autologous hematopoietic stem cell transplantation for acute leukemia was introduced in 1995.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Hematology |
|---|---|
| Doctors listed | 16 |
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us